Previous 10 | Next 10 |
Lantheus Holdings (LNTH +13.5%) shares have reached a four-month high in morning hours despite lower than expected earnings posted by the company for Q3 2021. However, its updated outlook has exceeded the Street forecasts, The North Billerica, Massachusetts-based healthcare supplier has ...
Lantheus (NASDAQ:LNTH): Q3 Non-GAAP EPS of -$0.08 misses by $0.14; GAAP EPS of -$0.20 misses by $0.18. Revenue of $102.07M (+15.3% Y/Y) beats by $4.94M. Press Release For further details see: Lantheus EPS misses by $0.14, beats on revenue
Worldwide revenue of $102.1 million for the third quarter 2021, representing an increase of 15.3% from the prior year period GAAP net loss of $13.4 million for the third quarter 2021, compared to GAAP net loss of $6.4 million in the prior year period GAAP fully d...
Lantheus (NASDAQ:LNTH) is scheduled to announce Q3 earnings results on Thursday, November 4th, before market open. The consensus EPS Estimate is $0.06 (+50.0% Y/Y) and the consensus Revenue Estimate is $97.13M (+9.7% Y/Y). Over the last 2 years, LNTH has beaten EPS estimates 100% of the time ...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Russell 2000 Value Index partially closed its multiye...
NORTH BILLERICA, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, November 4, 2021, to discuss its financial and operating results fo...
The following slide deck was published by Lantheus Holdings, Inc. in conjunction with this event. For further details see: Lantheus Holdings (LNTH) presents at Baird 2021 Global Healthcare Conference
NORTH BILLERICA, Mass., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to fi...
NORTH BILLERICA, Mass. and HAYWARD, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus) and RefleXion Medical, Inc., today announced a development and commercialization collaboration to evaluate the use of piflufolastat F 18, Lantheus’ prostat...
The following slide deck was published by Lantheus Holdings, Inc. in conjunction with this event. For further details see: Lantheus Holdings (LNTH) Investor Presentation
News, Short Squeeze, Breakout and More Instantly...
Lantheus Holdings Inc. Company Name:
LNTH Stock Symbol:
NASDAQ Market:
Lantheus Holdings Inc. Website:
2024-08-01 08:00:12 ET David Turkaly from JMP Securities issued a price target of $125.00 for LNTH on 2024-08-01 07:13:00. The adjusted price target was set to $125.00. At the time of the announcement, LNTH was trading at $104.83. The overall price target consensus is at...
Second Quarter 2024 Worldwide revenue of $394.1 million, an increase of 22.5% from second quarter 2023 Completed three strategic transactions to expand innovative pipeline GAAP fully diluted earnings per share of $0.88, compared to $1.33 in second quarter 2023. Adjusted fully ...
BEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, July 31, 2024, to discuss its financial and operating results for the second...